Print this page

Shimadzu - Solutions for Science since 1875

You are here: >> Home > Markets Overview > Pharma

Home Company Products Markets Customer Support Events Career Opportunities Press

Imprint Contact Sitemap

Pharma

News

FDA Issues Guidance for Industry on ANDAs: Impurities in Drug Products

The US Food and Drug Administration (FDA) announced the new guidance for industry entitled “ANDAs: Impurities in Drug Products” (Update of 1998 Draft Guidance).
For further information click here

Pharma News

NEWS Pharma Special
40 pages Shimadzu solutions following the drug discovery and development process from lead generation to quality control

>> More info

Links

Sum Parameters

TOC

Chromatography

Comprehensive

Testing Machine

EZ-Test

Spectroscopy

EDX

Chromatography

GC-2010Plus

Mass Spectrometry

GCMS-QP2010 Ultra

Chromatography

Nexera UHPLC

Spectroscopy

ICPE-9000

Moisture Balance

MOC-120H

Spectroscopy

AA-7000

LCMS Spectrometry

LCMS 2020

Spectroscopy

IRAffinity-1

Chip Electrophoresis

MultiNa

Spectroscopy

UV-1800

From Drug Discovery to Quality Control Shimadzu provides a wide range of Solutions and Support. Thanks to our long history in the market, our comprehensive product portfolio, our expertise in Regulatiory Compliance related issues and our worldwide reputation we are convinced that Shimadzu is the right partner for the Pharmaceutical Industry.
Especially with the Pharmaceutical Industry we are keeping Global relations and therefore Shimadzu maintains a Global Website for the Pharmaceutical segment. Click on the link below to access Shimadzus Global Pharma web site:

http://www.shimadzu.com/pharma/